Cellectar Biosciences (CLRB) Analyst & Key Data

Analyst Consensus

Buy1 analysts

Buy

Updated Sep 12, 2026

Total Analysts1

Buy

7

Hold

1

Ratings

Updated Sep 12, 2026

Overall Rating

B

DCF Score5.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score4.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$2.31

Median Target+376.19%

$11.00

Potential upside vs current price

DCF Value+89.91%

$4.39

Potential upside vs current price

Current Stock Price

$2.31

Median Target+376.19%

$11.00

Potential upside vs current price

DCF Value+89.91%

$4.39

Potential upside vs current price

Analyst Consensus

Buy1 analysts

Buy

Updated Sep 12, 2026

Total Analysts1

Buy

7

Hold

1

Ratings

Updated Sep 12, 2026

Overall Rating

B

DCF Score5.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score4.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$2.31

Median Target+376.19%

$11.00

Potential upside vs current price

DCF Value+89.91%

$4.39

Potential upside vs current price

Current Stock Price

$2.31

Median Target+376.19%

$11.00

Potential upside vs current price

DCF Value+89.91%

$4.39

Potential upside vs current price

Cellectar Biosciences, Inc.